Impaired synaptic function is linked to cognition in Parkinson's disease

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia

(2016) Erika Bereczki et al.   Alzheimers & Dementia

Increased CSF neurogranin concentration is specific to Alzheimer disease

(2016) Henrietta Wellington et al.   NEUROLOGY

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases

(2016) Erik Hessen et al.   Journal of Parkinsons Disease

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

(2015) Hlin Kvartsberg et al.   Alzheimers & Dementia

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

(2015) Kaj Blennow et al.   Alzheimers & Dementia

Age and amyloid effects on human central nervous system amyloid-beta kinetics

(2015) Bruce W. Patterson et al.   ANNALS OF NEUROLOGY

β-Amyloid and α-Synuclein Cooperate To Block SNARE-Dependent Vesicle Fusion

(2015) Bong-Kyu Choi et al.   BIOCHEMISTRY

Parkinson’s disease dementia: a neural networks perspective

(2015) James Gratwicke et al.   BRAIN

First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression

(2015) Damian M. Cummings et al.   BRAIN

Hippocampal Complex Atrophy in Poststroke and Mild Cognitive Impairment

(2015) Per Selnes et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease

(2015) Ane Løvli Stav et al.   PARKINSONISM & RELATED DISORDERS

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo

(2014) Edward Rockenstein et al.   BRAIN

Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases

(2014) Claudio Hetz et al.   NATURE REVIEWS NEUROSCIENCE

Brain amyloid-β oligomers in ageing and Alzheimer’s disease

(2013) Sylvain E. Lesné et al.   BRAIN

Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease

(2013) Mona K. Beyer et al.   MOVEMENT DISORDERS

Cerebrospinal fluid biomarkers in Parkinson disease

(2013) Lucilla Parnetti et al.   Nature Reviews Neurology

The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?

(2013) James Gratwicke et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Proteolytic Degradation of Amyloid  -Protein

(2013) T. Saido et al.   Cold Spring Harbor Perspectives in Medicine

EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease

(2012) A. Berardelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia

(2012) Yaroslau Compta et al.   PARKINSONISM & RELATED DISORDERS

Mild Cognitive Impairment in Parkinson’s Disease

(2011) Dag Aarsland et al.   Current Neurology and Neuroscience Reports

Synaptic Protein Alterations in Parkinson’s Disease

(2011) Ilse S. Pienaar et al.   MOLECULAR NEUROBIOLOGY

Deconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease

(2011) Baris Bingol et al.   NEURON

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia

(2010) Walter J. Schulz-Schaeffer   ACTA NEUROPATHOLOGICA

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

(2010) Annika Thorsell et al.   BRAIN RESEARCH

CSF amyloid-  and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

(2010) G. Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

(2010) J. C. Klein et al.   NEUROLOGY

[11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson’s disease with and without dementia

(2010) Pekka Jokinen et al.   PARKINSONISM & RELATED DISORDERS

Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease

(2010) James B. Leverenz et al.   PARKINSONISM & RELATED DISORDERS

Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET

(2009) Inga Liepelt et al.   MOVEMENT DISORDERS

Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated Species†

(2008) Daniel Sevlever et al.   BIOCHEMISTRY

Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study

(2008) D. Aarsland et al.   NEUROLOGY

Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo

(2008) John R. Cirrito et al.   NEURON